G01N 33/57545
Of the ovaries
Official title: of the ovaries
G01N33/57545 (Of the ovaries) appears on 497 US grants and 1,054 published applications in this corpus.
Search patents in G01N- Granted patents
- 497
- Published applications
- 1,054
- Assignees
- 448
- Inventors
- 1,680
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 9 | 0 |
| 2000 | 3 | 0 |
| 2001 | 7 | 0 |
| 2002 | 2 | 14 |
| 2003 | 3 | 49 |
| 2004 | 5 | 26 |
| 2005 | 8 | 38 |
| 2006 | 5 | 30 |
| 2007 | 16 | 46 |
| 2008 | 12 | 39 |
| 2009 | 15 | 46 |
| 2010 | 29 | 65 |
| 2011 | 24 | 48 |
| 2012 | 24 | 43 |
| 2013 | 27 | 44 |
| 2014 | 22 | 68 |
| 2015 | 28 | 60 |
| 2016 | 21 | 57 |
| 2017 | 26 | 68 |
| 2018 | 25 | 49 |
| 2019 | 33 | 38 |
| 2020 | 22 | 36 |
| 2021 | 28 | 37 |
| 2022 | 26 | 42 |
| 2023 | 13 | 34 |
| 2024 | 17 | 31 |
| 2025 | 18 | 28 |
| 2026 | 12 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Methods for the detection and treatment of ovarian cancer22 Sep 2026US 12,742,780 B2Board of Regents, The University of Texas System
- Molecular profiling of tumors21 Jul 2026US 12,687,554 B2Caris MPI, Inc.
- Method for the treatment or prophylaxis of cancer by targeting the extracellular portion of keratin 14 (KRT14) residing on cancer cells7 Jul 2026US 12,673,985 B2Hudson Institute of Medical Research
- Method for peritoneal metastatic cell detection and isolation thereof7 Jul 2026US 12,674,795 B2Versitech Limited
- Glycoprotein biomarkers for ovarian cancer diagnosis1 Oct 2026US 2026/0298932 A1Proseek Bio Pty Ltd.
- Antibodies and assays for detection of folate receptor 124 Sep 2026US 2026/0286003 A1ImmunoGen, Inc.
- Antibodies To Cell Adhesion Molecule-Related/Down-Regulated By Oncogenes (CDON) And Uses Thereof17 Sep 2026US 2026/0274945 A1Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
- Molecular profiling of tumors3 Sep 2026US 2026/0259233 A1Caris MPI, Inc.
- Diagnostic kits and methods for early detection of ovarian cancer20 Aug 2026US 2026/0243771 A1Ramot at Tel-Aviv University Ltd.
Most cited
By later US patents
- Biomarker for ovarian and endometrial cancer: hepcidin91US 7,510,842 B2Board of Regents, The University of Texas System · 2009
- Methods for the early diagnosis of ovarian cancer85US 6,294,344 B1Board of Trustees of the University of Arkansas · 2001
- Methods for the early diagnosis of ovarian, breast and lung cancer85US 6,316,213 B1Board of Trustees of the University of Arkansas · 2001
- Methods for the early diagnosis of ovarian cancer80US 6,268,165 B1Board of Trustees of the University of Arkansas · 2001
- Single chain B3 antibody fusion proteins and their uses60US 5,608,039 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1997